Zeman M, Jirak R, Vecka M, et al. N-3 polyunsaturated fatty acids in psychiatric diseases: mechanisms and clinical data[J]. Neuro Endocrinol Lett, 2012, 33(8):736-748.
[10]
Magoulas PL, El-Hattab AW. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management[J]. Orphanet J Rare Dis, 2012, 7:68.
[11]
Strijbis K, Vaz FM, Distel B. Enzymology of the carnitine biosynthesis pathway[J]. IUBMB Life, 2010, 62(5):357-362.
Furuta GT, Williams K, Kooros K, et al. Management of constipation in children and adolescents with autism spectrum disorders[J]. Pediatrics, 2012, 130 Suppl 2:S98-105.
[14]
Sonne S, Shekhawat PS, Matern D, et al. Carnitine deficiency in OCTN2-/-newborn mice leads to a severe gut and immune phenotype with widespread atrophy, apoptosis and a pro-inflammatory response[J]. PLoS One, 2012, 7(10):e47729.
